Literature DB >> 15348788

In vitro complement activation after contact with pyrolytic carbon-coated and uncoated polyethylene terephthalate.

E Cenni1, D Granchi, G Ciapetti, S Stea, E Verri, S Gamberini, A Gori, A Pizzoferrato, P Zucchelli.   

Abstract

This study was undertaken to evaluate whether the pyrolytic carbon coating of polyethylene terephthalate induces complement activation. Complement activation induced by pyrolytic carbon-coated polyethylene terephthalate (PET+PC) in comparison with uncoated polyethylene terephthalate (PET) was assessed on whole blood collected with heparin. The activation of the classic pathway was evaluated by C4d fragment enzyme immunoassay. The activation of the alternative pathway was evaluated with Bb fragment enzyme immunoassay. The results show that uncoated PET activates the alternative pathway, but not the classic one. PET+PC does not induce complement activation, not even through the alternative pathway. Pyrolytic carbon coating therefore contributes to improving blood compatibility.

Entities:  

Year:  1997        PMID: 15348788     DOI: 10.1023/a:1018564629533

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  24 in total

1.  In vitro endothelialization of carbon-coated Dacron vascular grafts.

Authors:  F Bernex; J P Mazzucotelli; J L Roudiere; N Benhaiem-Sigaux; J Leandri; D Loisance
Journal:  Int J Artif Organs       Date:  1992-03       Impact factor: 1.595

Review 2.  Complement activation and cytokine production as consequences of immunological bioincompatibility of extracorporeal circuits.

Authors:  G Jahns; N Haeffner-Cavaillon; U E Nydegger; M D Kazatchkine
Journal:  Clin Mater       Date:  1993

3.  Intracellular control of human neutrophil secretion. I. C5a-induced stimulus-specific desensitization and the effects of cytochalasin B.

Authors:  P M Henson; B Zanolari; N A Schwartzman; S R Hong
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

4.  In vivo induction of interleukin-1 during hemodialysis.

Authors:  N Haeffner-Cavaillon; J M Cavaillon; C Ciancioni; F Bacle; S Delons; M D Kazatchkine
Journal:  Kidney Int       Date:  1989-05       Impact factor: 10.612

5.  Complement activation produced by biomaterials.

Authors:  D E Chenoweth
Journal:  ASAIO Trans       Date:  1986 Jul-Sep

6.  Complement activation by plasma separator membranes.

Authors:  B C McLeod; A Viernes; R J Sassetti
Journal:  Transfusion       Date:  1983 Mar-Apr       Impact factor: 3.157

7.  Effect of complement and arachidonic acid pathway inhibition on white blood cell count and deposition on vascular grafts.

Authors:  E J Plecha; B R Kaufman; C K Vincent; Y S Kwak; D J DeLuca; L M Graham
Journal:  ASAIO Trans       Date:  1990 Jul-Sep

8.  Human platelet-initiated formation and uptake of the C5-9 complex of human complement.

Authors:  T S Zimmerman; W P Kolb
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

9.  Platelet and coagulation factor variations induced in vitro by polyethylene terephthalate (Dacron) coated with pyrolytic carbon.

Authors:  E Cenni; C R Arciola; G Ciapetti; D Granchi; L Savarino; S Stea; D Cavedagna; T Curti; G Falsone; A Pizzoferrato
Journal:  Biomaterials       Date:  1995-09       Impact factor: 12.479

10.  Leukocyte aggregation response to quantitative plasma levels of C3a and C5a.

Authors:  J J Williams; S A Yellin; G J Slotman
Journal:  Arch Surg       Date:  1986-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.